Literature DB >> 1696337

Malignant pleural mesothelioma: a survival study.

J C Harvey1, E H Fleischman, A R Kagan, O E Streeter.   

Abstract

Ninety-four patients with malignant pleural mesothelioma were treated at Southern California Permanente Medical Group Facilities between 1965 and 1988. This retrospective analysis of survival in these patients is compared according to surgical and/or supportive management. Group I patients received supportive care only, including pleurodesis as needed. This group included the majority of patients. Group II patients were managed largely with debulking procedures including decortication and pleurectomy. Group III patients received extrapleural pneumonectomy. This group included the two long-term survivors of the entire group. This study of survival points out the need for a cooperative protocol as well as the consistent use of proper modern preoperative staging in an attempt to select patients who benefit from extrapleural pneumonectomy.

Entities:  

Mesh:

Year:  1990        PMID: 1696337     DOI: 10.1002/jso.2930450109

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN: 0022-4790            Impact factor:   3.454


  6 in total

Review 1.  A systematic review of lung-sparing extirpative surgery for pleural mesothelioma.

Authors:  Elaine Teh; Francesca Fiorentino; Carol Tan; Tom Treasure
Journal:  J R Soc Med       Date:  2011-02       Impact factor: 5.344

2.  Extrapleural pneumonectomy for diffuse malignant pleural mesothelioma. A treatment option in selected cases?

Authors:  K Takahashi; J Yoshida; M Nishimura; K Nagai
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  2001-02

3.  Targeting mesothelioma using an infectivity enhanced survivin-conditionally replicative adenoviruses.

Authors:  Zeng B Zhu; Sharmila K Makhija; Baogen Lu; Minghui Wang; Shuyi Wang; Koichi Takayama; Gene P Siegal; Paul N Reynolds; David T Curiel
Journal:  J Thorac Oncol       Date:  2006-09       Impact factor: 15.609

Review 4.  Diffuse malignant mesothelioma of the pleura: a clinicopathological study of six patients with a prolonged symptom-free interval or extended survival after biopsy and a review of the literature of long-term survival.

Authors:  E J Mark; D H Shin
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1993

5.  Gemcitabine combined with oxaliplatin in pretreated patients with malignant pleural mesothelioma: an observational study.

Authors:  Athanasios Xanthopoulos; Torsten T Bauer; Torsten G Blum; Jens Kollmeier; Nicolas Schönfeld; Monika Serke
Journal:  J Occup Med Toxicol       Date:  2008-12-18       Impact factor: 2.646

6.  Multimodal treatment for resectable epithelial type malignant pleural mesothelioma.

Authors:  Ichiro Yoshino; Masafumi Yamaguchi; Tatsuro Okamoto; Chie Ushijima; Yasuro Fukuyama; Yukito Ichinose; Yoshihiko Maehara
Journal:  World J Surg Oncol       Date:  2004-05-05       Impact factor: 2.754

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.